Your browser is no longer supported

For the best possible experience using our website we recommend you upgrade to a newer version or another browser.

Your browser appears to have cookies disabled. For the best experience of this website, please enable cookies in your browser

We'll assume we have your consent to use cookies, for example so you won't need to log in each time you visit our site.
Learn more

Drug companies infiltrate journals

  • Comment
Ghost authorship in research papers 'serves the commercial purposes' of drug companies, a study has shown.

Ghost authorship in research papers 'serves the commercial purposes' of drug companies, a study has shown.

The researchers studied 44 industry-initiated trials. They found ghost authorship in 31 (75%) trials, which included writing the trial protocol, performing the statistical analyses, or writing the manuscript.

Ghost authorship increased to 91% when they included cases where a person qualifying for authorship was acknowledged rather than appearing as an author.

The authors concluded that protocols for authorship should be made publicly available, in order to 'improve transparency and accountability', avoid misleading readers and reduce the potential for manipulating analyses.

Public Library of Science Medicine (2007) Online publication: DOI: 10.1371/journal.pmed.0040019

  • Comment

Have your say

You must sign in to make a comment

Please remember that the submission of any material is governed by our Terms and Conditions and by submitting material you confirm your agreement to these Terms and Conditions. Links may be included in your comments but HTML is not permitted.